2023 Speaking Faculty
CHAIR: Mark Johnston, MD, FRCPCDirector CNS Research/Medical Director, Atlantic
Centricity Research
Joshua Woolley, MD, Ph.D.Associate Professor, Psychiatry
UCSF Weill Institute for Neurosciences
Gul Dolen, MD, Ph.D.Associate Professor of Neuroscience, Brain Institute, Wendy Klag Center
Johns Hopkins University
Gary Kay, Ph.D.Co-Founder & Chief Scientific Officer
Cognitive Research Corporation
Tim SchlidtCo-founder & Partner
Palo Santo
Boris Heifets, MD, Ph.D.Assistant Professor of Anesthesiology, Perioperative & Pain Medicine
Stanford University
Ryan Gumpper, Ph.D.Postdoctoral Research Associate and Project Manager of DARPA Focused Pharma Initiative
Univ. of North Carolina Chapel Hill
Amanda WayPrincipal
Jazz Venture Partners
Natalie Gukasyan, MDAssistant Prof., Dept. of Psychiatry & Behavioral Sciences, Medical Dir., Center for Psychedelic & Consciousness Research
Johns Hopkins University School of Medicine
James Kuo, MD, MBAVice President of R&D
Silo Pharma
Sabrina Ramkellawan, CCRP, CCRAChief Operating Officer & Co-Founder
AxialBridge (formerly known as Knowde Group)
Natasha Sumner, JDSenior Counsel
Husch Blackwell
Kimberly Chew, JDSenior Counsel
Husch Blackwell
Tom McDonaldChief Executive Officer
Clerkenwell Health
Anne DwanePartner
Village Global
Matthew Baggott, Ph.D.Co-founder & Chief Executive Officer
Tactogen
Dana Watt, Ph.D.Principal
Breakout Ventures
Sandeep Nayak, MDAssistant Professor, Department of Psychiatry & Behavioral Sciences, Behavioral Pharmacology Research Unit
Johns Hopkins Center for Psychedelic and Consciousness Research
Karen Luong, JDSenior Counsel
Husch Blackwell
Elliot Marseille, DrPH, MPPDirector
UC Berkeley/UCSF Global Initiative for Psychedelic Science Economics
Principal
Health Strategies International
Hailey Gilmore, MPHMedical Affairs Program Manager
MAPS Public Benefit Corporation
Graham Pechenik, JDFounder, Patent Attorney
Calyx Law
Christine Moore, Ph.D.VP, Neuroscience, Scientific Solutions
Worldwide Clinical Trials
Anton Avanceña, Ph.D.Assistant Professor of Health Outcomes
University of Texas at Austin College of Pharmacy
James LanthierChief Executive Officer
Mindset Pharma
Clare KnightSenior Clinical Trials Manager
Clerkenwell Health
Harpreet Kaur, Ph.D.Vice President of Research
PharmAla Biotech
Brett WatersCo-Founder & Executive Director
Reason for Hope
Associate Attorney
Winston & Strawn
Charlotte Smith, Ph.D.Associate Professor in Management and Organisation, School of Business
University of Leicester
Matthew ZornPartner
Yetter Coleman
Benjamin LightburnCEO & Co-Founder
Filament Health
Gisele Fernandes-Osterhold, MFTDirector of Psychedelic Facilitation, Translational Psychedelic Research Program (TrPR), BAND Lab
University of California San Francisco
Shahin ShamsData Curator
Porta Sophia
Greg DwuletPatent Agent
Calyx Law
Matias SerebrinskyCo-Founder
Psymed Ventures
Max VargasPh.D. Candidate, Neuroscience Graduate Program
University of California, Davis
